| Primary |
| Muscle Spasms |
62.1% |
| Product Used For Unknown Indication |
16.5% |
| Pain |
3.2% |
| Drug Abuse |
2.8% |
| Malaria |
2.1% |
| Pain In Extremity |
2.1% |
| Hypertension |
1.8% |
| Restless Legs Syndrome |
1.8% |
| Diabetes Mellitus |
1.4% |
| Drug Level |
1.4% |
| Dermatitis |
0.7% |
| Drug Dependence |
0.7% |
| Infection |
0.7% |
| Suicide Attempt |
0.7% |
| Abortion Induced |
0.4% |
| Adverse Drug Reaction |
0.4% |
| Arthritis |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Dyspepsia |
0.4% |
| Gout |
0.4% |
|
| Thrombocytopenia |
28.2% |
| Unevaluable Event |
13.7% |
| Renal Failure |
10.5% |
| Vomiting |
7.3% |
| Blood Disorder |
5.6% |
| Blindness |
4.8% |
| Thrombotic Thrombocytopenic Purpura |
4.8% |
| Off Label Use |
3.2% |
| Idiopathic Thrombocytopenic Purpura |
2.4% |
| Pain |
2.4% |
| White Blood Cell Count Increased |
2.4% |
| Angiopathy |
1.6% |
| Arrhythmia |
1.6% |
| Bladder Cancer |
1.6% |
| Deafness |
1.6% |
| Drug Interaction |
1.6% |
| Electrocardiogram Qt Prolonged |
1.6% |
| Haematoma |
1.6% |
| Haemorrhage |
1.6% |
| Hepatic Failure |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
35.6% |
| Muscle Spasms |
17.9% |
| Drug Use For Unknown Indication |
10.6% |
| Hypertension |
7.4% |
| Rheumatoid Arthritis |
4.4% |
| Pain |
4.3% |
| Anaesthesia |
4.0% |
| Asthma |
2.2% |
| Muscle Relaxant Therapy |
2.2% |
| Duodenal Ulcer |
2.1% |
| Hypercholesterolaemia |
1.5% |
| Ill-defined Disorder |
1.5% |
| Angina Pectoris |
1.4% |
| Blood Cholesterol Increased |
0.9% |
| Prophylaxis |
0.9% |
| Multiple Myeloma |
0.8% |
| Plasmodium Falciparum Infection |
0.6% |
| Staphylococcal Infection |
0.6% |
| Anaesthesia Procedure |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.5% |
|
| Renal Failure |
10.5% |
| Thrombocytopenia |
9.0% |
| Vomiting |
7.5% |
| Completed Suicide |
6.8% |
| Death |
6.8% |
| Non-hodgkin's Lymphoma |
6.0% |
| Unevaluable Event |
6.0% |
| Vestibular Disorder |
6.0% |
| Malaise |
4.5% |
| Purpura |
4.5% |
| Renal Failure Acute |
4.5% |
| Drug Hypersensitivity |
3.8% |
| Respiratory Arrest |
3.8% |
| Therapeutic Response Decreased |
3.8% |
| Gastrointestinal Disorder |
3.0% |
| Pyrexia |
3.0% |
| Syncope |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Body Mass Index Decreased |
2.3% |
| Haematoma |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.1% |
| Drug Use For Unknown Indication |
23.2% |
| Muscle Spasms |
6.8% |
| Hypertension |
5.0% |
| Pain |
4.8% |
| Rheumatoid Arthritis |
3.0% |
| Osteoporosis |
2.8% |
| Diabetes Mellitus |
2.6% |
| Nuclear Magnetic Resonance Imaging |
2.6% |
| Multiple Myeloma |
2.1% |
| Depression |
2.0% |
| Nausea |
2.0% |
| Arthritis |
1.9% |
| Blood Cholesterol Increased |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Prophylaxis |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Anxiety |
1.4% |
| Asthma |
1.2% |
| Parkinson's Disease |
1.2% |
|
| Vomiting |
15.6% |
| Weight Increased |
14.6% |
| Weight Decreased |
7.7% |
| Death |
6.0% |
| Urinary Tract Infection |
6.0% |
| Myocardial Infarction |
4.6% |
| Renal Failure Acute |
4.2% |
| Nausea |
4.0% |
| Pain |
3.5% |
| Sepsis |
3.5% |
| Tendon Rupture |
3.5% |
| Pneumonia |
3.3% |
| Respiratory Failure |
3.1% |
| Skin Ulcer |
3.1% |
| Cerebrovascular Accident |
2.9% |
| Rhabdomyolysis |
2.9% |
| Transient Ischaemic Attack |
2.9% |
| Tremor |
2.9% |
| X-ray Abnormal |
2.9% |
| Malaise |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Hiv Infection |
35.7% |
| Abdominal Pain Upper |
3.6% |
| Bladder Disorder |
3.6% |
| Malaria |
3.6% |
| Plasmodium Falciparum Infection |
3.6% |
|
| Drug Interaction |
50.0% |
| Epistaxis |
25.0% |
| Weight Increased |
25.0% |
|
